Super critical CO2 Technology for decellularization, impregnation & sterilization of tussiues

HCM-Medical has developed a novel decellularization & sterilization of xenograft & allograft –derived biological
scaffold tissues using scCO2 technology with minimal/no damage to native Extra Cellular Matrix(ECM) composition
& growth factor resulting in an excellent biocompatibility & tissue integration upon implantation. HCM currently
manufactures CE/FDA approved collagen membranes, bone fillers derived from xenografts & allografts using scCO2

scCO2 TechnologyNCD_HCM-Medical